Robot Completes 26 Cataract Surgeries With Surgeon in Control

ForSight Robotics has announced that its JASPER Robotic Surgical Platform has successfully completed 26 fully robotic-assisted cataract surgeries on human patients. According to the company, every procedure was finished robotically, without the surgeon needing to revert to manual operation.

Surgeon-Controlled Telemanipulation

The JASPER platform operates through surgeon-controlled telemanipulation. A surgeon directs the procedure, and the robotic system translates these commands into precise movements within the patient's eye. This approach allows the surgeon to maintain full control while the robot executes the delicate physical tasks. The system provides surgeons with high-definition 3D visualization, can scale movements, and filter out natural hand tremors. Real-time eye tracking and computer vision are also integrated to assist the surgeon during the operation.

Unlike some other robotic surgery approaches, JASPER is designed to perform the complete cataract procedure rather than just a single part of it. This means the surgeon, who remains in charge throughout, decides and directs all actions.

Integration into Standard Care

ForSight Robotics aims to integrate its robotic technology into the existing framework of cataract surgery. The company stated that all 26 procedures were completed without converting to conventional manual surgery. Patients received standard anesthesia, either topical or mild sedation, and were discharged the same day, mirroring the typical experience for outpatient cataract surgery.

Cataract surgery is a common procedure performed globally, with ForSight Robotics noting over 30 million operations annually worldwide. The company suggests that if systems like JASPER are proven safe and practical, they could impact a large number of patients.

Early Clinical Experience

While the company reports that 100% of the 26 procedures were completed robotically without manual conversion, ForSight emphasizes this is early clinical experience. The JASPER system is still under design and development and has not yet received approval for commercial use. Further studies and regulatory submissions are planned. The 100% figure specifically refers to the robotic completion of the procedure and does not indicate a universal success rate or prove the system is safer than conventional methods. Long-term patient outcomes are also yet to be determined.

Future Potential

ForSight Robotics views the JASPER system as a potential foundation for future AI-enabled surgical tools. The company believes the technology could offer surgeons enhanced precision and stability. However, for patients requiring cataract surgery today, this technology does not currently alter treatment options as it is not yet a commercially available system. The development represents a potential evolution in surgical procedures, where robotic systems translate surgeon commands into highly precise movements.